Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cell membrane wikipedia , lookup
Cytokinesis wikipedia , lookup
Extracellular matrix wikipedia , lookup
Cell culture wikipedia , lookup
Cellular differentiation wikipedia , lookup
Signal transduction wikipedia , lookup
Tissue engineering wikipedia , lookup
Organ-on-a-chip wikipedia , lookup
Cell encapsulation wikipedia , lookup
Endomembrane system wikipedia , lookup
Enzymatic Evidence for Differences in the Placement of Rh Antigens Within the Red Cell Membrane By Kimita Suyama and Jack Goldstein Intact erythrocytes of different Rh genotypes w e r e subjected to various enzyme treatments, t h e effects of which w e r e monitored by separating t h e membrane proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and performing Western blotting using a n antibody preparation t h a t recognizes only Rh-related polypeptides. W e found t h a t treatment of intact cells with either phospholipase A, or proteases such as papain did not alter t h e size of Rh antigen-containing polypeptides. In contrast, phospholipase A, treatment followed by papain digestion cleaved a fraction of t h e s e polypeptides. This cleavage appears, from such digestions of Rh(D) positive and negative cells of different genotypes, to occur solely at t h e extracellular domain of Rh(D) polypeptide, while t h e extracellular domains of other Rh antigen-containing polypeptides a r e unaffected. Digestion of red blood cell g h o s t s and insideo u t vesicles with trypsin showed t h a t Rh(D), (C/c), and (E/e) antigen-containing polypeptides span t h e lipid bilayer having cytoplasmic domains susceptible to t h e action of proteases. T h e size of t h e cleavage products at t h e cytoplasmic domain of -D-/-Dcells was found to differ from t h a t of other Rh(D) positive genotypes, d u e possibly to a difference in folding of Rh(D) polypeptide at its cytoplasmic domain and within t h e cellular membrane of t h e s e cells. 0 1990 by The American S o c i e t y of Hematology. M NY; and MPL + TDM + CWS adjuvant emulsion from RIB1 Immunochemical Research Inc, Hamilton, MT. Enzymatic treatment of erythrocytes. RBCs were prepared by washing three times in saline and three times in phosphate buffered saline (PBS), pH 7.4, spinning at 2,500 rpm for 8 minutes and aspirating the buffy coat. For phospholipase A, digestion, the procedure of Verkleij et all' was followed with some modification. Cells, at a concentration of 20% unless otherwise indicated, were incubated with phospholipase A, (20 U/mL) in buffer containing 20 mmol/L Tris-HCI, 150 mmol/L NaCl, 25 mmol/L glucose, and 10 mmol/L CaCl,, pH 7.4, at 37°C for 2 hours. Under these conditions phospholipase A, specifically converts 60% to 70% of the lecithin present in the outer lipid bilayer of intact cells into lisolecithin without hemolysing the cells." Treated cells were then immediately washed twice in buffer containing 20 mmol/L Tris-HC1, 150 mmol/L NaCl, 25 mmol/L glucose, and 3 mmol/L EDTA, pH 7.4, and once in PBS, pH 7.4. Aliquots of these cells were then further digested by papain, again at cell concentrations of 20%,in PBS, pH 7.4. Incubation was for 2 hours at 37OC, 10 mmol/L dithiothreitol was added to the buffer, and the enzyme level was either 0.1% papain in 2.7 mmol/L L-cysteine or 0.25% papain in 6.7 mmol/L Lcysteine. Incubations were followed immediately with three washes in PBS, pH 7.4. Membrane samples to be applied to 12% acrylamide mini-gels were prepared from similar volumes of packed cells by lysing the cells in 5 mmol/L sodium phosphate buffer, pH 7.4, and washing the membranes at least three times with the same buffer to remove adhering hemoglobin. Trypsin treatment of unsealed ghosts and sealed inside-out vesicles. Unsealed RBC ghosts were prepared as described by Jennings et al,I9and sealed inside-out vesicles by the method of Steck and Kant.*' A 5% suspension of either unsealed ghosts or sealed inside-out vesicles in 10 mmol/L sodium phosphate buffer, pH 7.4, OLECULAR PROPERTIES of antigens of the Rh blood group system are currently the subject of intensive investigation.' Rh(D) antigen, the most important clinically, and the two commonly detected antigenic alleles, (C/c) and (E/e), which are usually expressed along with it, have been shown to be associated with polypeptides having apparent molecular weights (mol wts) in the range of 28,000 to 35,000 daltons.*-*These appear to be nonglyc~sylated~ integral membrane proteins recently shown to contain thiollinked fatty acids." Thus far, only partial amino acid sequences have been determined."-I3 Reports indicating slight but reproducible electrophoretic differences between Rh(D), (C), and (E) p01ypeptides,8"~as well as those showing variation in their one- and two-dimensional peptide "maps" after radioiodination and pr~teolysis,"~'~~'~ suggest that these antigens are components of similar but not structurally identical proteins. What, if any, relationship these antigens have in maintaining viable erythrocyte membrane structures, or why Rh(D) is more immunoreactive than (C/c) or (E/e) is not yet known. As a first step toward answering these questions, we describe results of enzymatic treatment of intact cells, ghosts, and inside-out vesicles that provide further evidence for Rh antigen-containing polypeptides spanning the membrane of the red blood cell (RBC). Our results also suggest that Rh(D) polypeptide differs from Rh (E/e) and (C/c) polypeptides in the manner in which its extracellular domain is presented on the surface of the cell. MATERIALS AND METHODS Materials. Fresh RBCs (cDE/cDE, CDe/CDe, cde/cde) were obtained from The New York Blood Center (New York, NY) and rare RBCs (Rh-null regulator type, -D-/-D-, cdE/cdE, Cde/ d e ) from Ortho Diagnostic Systems, Plainfield, NJ. Human monoclonal anti-Rh(D) was purchased from Bioproducts for Science Inc, Indianapolis, IN, and goat anti-rabbit immunoglobulin G (1gG)HRP conjugate from Cooper Biomedical, Malvern, PA. Anti-human IgG-agarose, phospholipase A, from Naja mocambique mocambique, trypsin from bovine pancreas, and N-#I-tosyl-L-lysinechloromethyl ketone (TLCK) were provided by Sigma, St Louis, MO. Papain was ordered from Aldrich, Milwaukee, WI; L-cysteine from Calbiochem, San Diego, CA; dextran T-1 10 from Pharmacia, Piscataway, NJ; nitrocellulose paper from Schleicher & Schuell, Keene, NH; 4-chlore 1-naphthol from Bio-Rad, Rockville Center, Blood, Vol75, No 1 (January 1). 1990 pp 255-260 From the Lindsley F, KimbaN Research Institute of the New York Blood Center, New York, NY. Submitted June 26, 1989; accepted August 30, 1989. Supported in part by the Ofice of Naval Research contract No. NO001 4-84-C-0543. Address reprint requests to Jack Goldstein, PhD, The New York Blood Center, 310 E 67th St, New York. N Y 10021. The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C.section 1734 solely to indicate this fact. 0 1990 by The American Society of Hematology. 0006-4971/90/7501-0023$3.00/0 255 SUYAMA AND GOLDSTEIN 256 containing 150 mmol/L KCI, was incubated with 50 pg/mL trypsin at 37°C for 45 minutes. Then TLCK was added immediately to a final concentration of 50 pg/mL. Five minutes later the ghosts or vesicles were recovered by centrifugation at 22,000 x g for 30 minutes. Wesrern blot immunosraining assay. Sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) was performed under the nonreducing conditions reported by Laemmli” using 12% acrylamide gel concentrations and membrane samples diluted with an equal volume of loading buffer. Transfer to nitrocellulose paper and immunostaining of the separated membrane proteins was done as reported by Burnette” and modified by Bio-Rad Laboratories as described under catalog number 170-3930 entitled “Mini Trans-Blot Electrophoretic Transfer Cell Instruction Manual” (1986, p I). The rabbit antibody preparation recently reported by us to immunostain Rh antigen-containing polypeptides’ was used at a 1:1,000 dilution for studies described here. RESULTS Action of papain on Rh antigens of RBCs pretreated with phospholipase A,. Treatment of intact Rh(D) positive RBCs (cDE/cDE) with either phospholipase A2 or papain did not affect the size of Rh-containing polypeptides. This was determined by preparing membranes from such cells, separating the membrane proteins by SDS-PAGE, and subjecting them to immunostaining with an antibody preparation recently found to react with Rh-related polypeptides.’ Under these conditions only one immunostained band in the 35-Kd region of the gel was observed (Fig I A , lanes 2 through 6). However, treatment of these cells in a sequential manner, first with phospholipase A,, followed by papain, produced a second antibody reactive band in approximately the 30-Kd region of the gel (Fig I A , lane 7). Identical results were obtained with CDe/CDe cells (data not shown). Increased cleavage of a 35-Kd protein band to 30 Kd was neither obtained by raising the level of papain from 0.25% to 0.8% nor by increasing the concentration of RBCs from 20% to 65%. Longer incubations with phospholipase A, and A papain also did not alter the relative amounts of the 35-Kd and 30-Kd bands, or produce other detectable cleavage products. Other proteases such as trypsin, chymotrypsin, and the carboxypeptidases (A, B, and Y), when used in place of papain, did not cleave any of the proteins in the 35-Kd region, while pronase produced only small amounts of the 30-Kd cleavage product (data not presented). When - D-/ -D- cells were treated in the same manner as other Rh(D) positive cells, significantly more cleavage of Rh antigen (which in this case consists of only Rh(D) polypeptide and thus exhibits an apparent mol wt under our SDS-PAGE conditions of 33-Kd to 30-Kd product) was observed. (Fig 1 B, lanes 2 and 3). In contrast, treatment of Rh(D) negative cells (cde/cde, cdE/cdE) with phospholipase A2and papain did not result in any detectable production of 30-Kd protein or any other cleavage product from the intact Rh-containing polypeptides in the 35-Kd region (Fig 2A, lanes 2 through 5; Fig 29, lanes 2 and 3). Identical results were obtained with Cde/cde cells (data not shown). We had shown previously that our antibody preparation would not react with any membrane proteins obtained from Rh-null regulator-type cells.’ Incubation of such cells with phospholipase A, followed by papain did not produce any immunoreactive cleavage products (Fig 29, lanes 4 and 5), thus ruling out the possibility that such treatment was producing a cross-reacting non-Rh related digestion product. Rh(D) polypeptide was isolated from both treated and untreated Rh( D) positive cells (cDE/cDE) by immune complex formation with a human polyclonal anti-D preparation as previously described.n Immunoblots of the isolated protein (Fig 3, lanes 1 and 2) show that phospholipase A, and papain digestion cleaved some, but not all, of the Rh(D) polypeptide producing the 30-Kd product. That only polypeptide containing the Rh(D) antigen is being cleaved under these conditions is strongly suggested by these results and I 2 3 4 5 6 7 MW- 9655- 9655-‘ 3629- 3629 - 18- 18- B 2 3 Fig 1. Western blots of Rh polypeptidesbefore and after enzyme treatment of intact Rh-positive (cDE/cDE, - D- / -D- 1 RBCs. Total membrane proteins prepared from similar volumes of pecked cells were separated by SDS-PAGE using e 12% polyacrylamide gel, transferred to nitrocellulose paper. and reacted with rabbit antibody (1:1,OOO dilution), followed by goat anti-rabbit IgG conjugated with horseradish peroxidase (1:2,OOO). (A) Lane 1, standard marker proteins; lanes 2 through 7. immunoreactive bands resulting from the following treatments of cDE/cDE cells: lane 2, untreated: lane 3, buffer; lane 4, phospholipase A,; lane 5. papain (0.1%); lane 6. phospholipase A, followed by buffer; lane 7, phospholipase A, followed by papain (0.1%).Identical results were obtained using CDe/CDe cells. (E) Lane 1, standard marker proteins: lanes 2 and 3. immunoreactive bands resulting from the following treatments of - D- / - D cells: lane 2, phospholipase A, followed by buffer; lane 3, phospholipase A, followed by papain (0.25%). PLACEMENT OF RH ANTIGENS IN THE RBC MEMBRANE 257 96- 96- 55- 55- ' - 3 6- 36 29- 29- 18- I8 . - Fig 2. Western blots of R h polypeptides before and after enzyme treatment of intact Rh-negative (cde/cde. cdE/cdEl and Rh-null regulator-type cells. Separation end immunostaining of membrane proteins were the same as described in the legend to Fig 1. (AI Lane 1, standard marker proteins; lanes 2 through 5, immunoreactive bands resulting from the following treatments of cde/cde cells: lane 2, untreated; lane 3, phospholipase A,; lane 4, papain; lane 5, phospholipase A, followed by papain. (Bl Lane 1. standard marker proteins; lanes 2 and 3,immunoreactive bands resulting from the following treatments of cdElcdE cells; lane 2, phospholipase A, followed by buffer; lane 3, phospholipase A, followed by papain (0.25%) (identical results were obtained using Cde/cde cells); lane 4, standard marker proteins; lanes 5 and 6, the lack of immunoreactive bands after the following treatments of Rh-null regulator-type cells: lane 5, phospholipase A, followed by buffer; lane 6, phospholipase A, followed by papain (0.25%). those described earlier; namely, that formation of the 30-Kd band is detected only after digestion of Rh(D) positive (including - D - / - D - ) cells but not after such treatment of Rh(D) negative cells having C/c and E/e antigens. -. I - 2 Fig 3. Western blots of Rh(Dl polypeptide isolated from treated end untreated intact cDE/cDE cells by immune complex formation with human polyclonal anti-D. Separation of the immune complexes (15 pg) and immunostaining with rabbit antibody were the same as described in the legend t o Fig 1. Lane 1, immune complex from untreated cells; lane 2, immune complex from phospholipase A, followed by papain-treated cells. A MW MW ' 18 Trypsin digestion of unsealed ghosts obtained from untreated or phospholipase A, and papain treated Rh(D) positive (cDElcDE, - D-1- D - ) and negative (cdelcde) cells. Immunoblots of tryptic digests of unsealed ghosts prepared from either untreated or phospholipase A> and papain-treated Rh( D) positive (cDE/cDE) cells showed the presence of two new polypeptide bands having apparent mol wts of approximately 20,000 and 17,000, respectively (Fig 4A, lanes 2 through 5). Identical results were obtained with other Rh(D) positive (CDe/CDe, data not shown) and Rh(D) negative (cde/cde) tryptic digests (Fig 4B, lanes 2 through 5). These results indicate that prior treatment of intact cells with phospholipase A, and papain, with formation of the 30-Kd cleavage product, was not a prerequisite for 8 364 29 b Fig 4. Western blots of R h polypeptides before and after trypsin digestion of ghosts prepared from either untreated or phospholipase A, and papain-treated R h positive (cDE/cDEl and negative (cde/cdel intact cells. Total membrane proteins prepared from similar volumes of packed ghosts were separated and immunostained as described in the legend to Fig 1. ( A ) Lane 1, standard marker proteins; lanes 2 through 5. immunoreactive bands obtained from cDE/cDE cells: lane 2. trypsin digestion of ghosts from cells treated with phospholipase A, followed by papain (0.1%);lane 3,ghosts from cells treated with phospholipase A, followed by papain (0.1%);lane 4, trypsin digestion of ghosts from nontreated cells; lane 5. ghosts from nontreated cells. Identical results were obtained using (CDe/CDel cells. ( 6 ) Lane 1, standard marker proteins; lanes 2 through 5, immunoreactive bands obtained from cde/cde cells: lane 2. ghosts from nontreated cells; lane 3.trypsin digestion of ghosts from nontreated cells; lane 4. ghosts from cells treated with phospholipase A, followed by papain (0.1%I; lane 5, trypsin digestion of ghosts from cells treated with phospholipase A, followed by papain (0.1%I. SUYAMA AND GOLDmIN 258 the production of 20-Kd and 17-Kd polypeptide bands. Furthermore, unsealed ghosts prepared from both Rh(D) positive or negative cells could be digested with trypsin to yield these immunoreactive bands. This suggests that the 20-Kd and 17-Kd polypeptides are cleavage products produced by the action of trypsin at the cytoplasmic domains of Rh(D), (C/c), and (E/e) antigens. In contrast, trypsin digestion of unsealed ghosts obtained from untreated -D-/-Dcells cleaved the Rh(D) polypeptide to produce two barely separable bands in about the 31-Kd to 32-Kd region of the gel (Fig 5, lanes 2 and 3). Phospholipase A, and papain treatment of intact -D-/ -D- cells produced the expected incomplete conversion of the 33-Kd Rh(D) polypeptide to the 30-Kd cleavage product (Fig 5, lane 4). Digestion of unsealed ghosts prepared from these cells with trypsin further cleaved these polypeptides to produce a second band in the 26-Kd region of the gel (Fig 5, lane 5). The size of the trypsin cleavage products obtained in these studies suggests that the arrangement of the cytoplasmic domain of Rh(D) polypeptide in -D-/-Dcells is different from that found in other Rh(D) positive cells. Trypsin digestion of inside-out vesicles obtained from Rh(D)positive (CDeICDe, - D-1- D - ) and Rh(D)negative (cdelcde) cells. To confirm that the results obtained with unsealed ghosts represented cleavage at the cytoplasmic domains of Rh antigens, we prepared inside-out vesicles from Rh(D) positive (CDe/CDe) and Rh(D) negative (cde/cde) cells that had not been pretreated with phospholipase A, plus papain, and digested these vesicles with trypsin. Such treatment produced two immunoreactive cleavage products of identical size (Fig 6A, lanes 2 and 3; Fig 6B, lanes 2 and 3) to those found as a result of trypsin digestion of unsealed ghosts A MW 2 3 XIO-3 9655- I ! 3 u 9 4 36- 2918- Fig 6. Western blots of R h polypeptides before and after trypsin digestion of inside-out vesicles prepared from R h positive (CDe/CDe) and negative (cdelcde) cells. Total membrane proteins prepared from approximately 200 pg of starting inside-out vesicles were separated and immunostained as described in the legend t o Fig 1. ( A ) Lane 1, standard marker proteins; lane 2, insideout vesicles from CDe/CDe cells; lane 3,trypsin digestion of insideout vesicles from CDelCDe cells. Identical results were obtained using cDE/cDE cells. (6)Lane 1, standard marker proteins; lane 2. inside-out vesicles from cdelcde cells; lane 3. trypsin digestion of inside-out vesicles from cde/cde cells. (Fig 4A, lanes 2 through 5; Fig 4B, lanes 2 through 5 ) . Identical results were obtained using cDE/cDE cells (data not shown). Similarly, trypsin cleaved the Rh(D) polypeg tides of inside-out vesicles prepared from - D - / - D- cells, producing two partially separable cleavage products (Fig 7, lanes 2 and 3) identical in size (31 to 32 Kd) to those found MW XIO-3- 96i 55i 291 36 I8i Fig 5. Western blots of Rh polypeptides before and after trypsin digestion of ghosts prepared from either untreated or phospholipase A, and papain-treated - D- / - D - intact cells. Total membraneproteins prepared from similar volumes of packed ghosts were separated and immunostained as described in the legend t o Fig 1. Lane 1, standard marker proteins; lanes 2 through 5. immunoreactive bends obtained from -D- / -D- cells: lane 2. ghosts from nontreated cells; lane 3, trypsin digestion of ghosts from nontreated cells; lane 4. ghosts from cells treated with phospholipase A, followed by papain (0.1%); lane 5. trypsin digestion of ghosts from cells treated with phospholipase A, followed by papain (0.1%). I I 2 3 96 :i 55i 18 Fig 7. Western blots of R h polypeptides before and after trypsin digestion of inside-out vesicles prepared from -D- / -Dcells. Total membrane proteins prepared from approximately 200 pg of starting inside-out vesicles were separated and immunostained as described in the legend t o Fig 1. Lane 1, standard marker proteins; lane 2. inside-out vesicles from -D- / -Dcells; lane 3, trypsin digestion of inside-out vesicles from -D-/ - D - cells. 259 PLACEMENT OF RH ANTIGENS IN THE RBC MEMBRANE with trypsin-treated unsealed ghosts from the same genotype (Fig 5, lanes 3 and 4). DISCUSSION Using a rabbit polyclonal antibody preparation recently shown to specifically immunostain Rh antigen-related polypeptides: we have been able to monitor the effects of various enzyme treatments on the structural integrity of Rh(D), (C/c), and (E/e) antigen-containing polypeptides in situ. Phospholipase A, treatment of intact erythrocytes has been reported to significantly reduce the antigenic activity of Rh(D) Similar incubations with proteases, on the other hand, apparently have no effect on the ability of Rh(D) antigen to interact with antibody, and no degradation of the polypeptide is observed." Treatment of intact cells with phospholipase A, under conditions where no hemolysis occurs, followed by digestion with papain again without producing hemolysis, resulted in cleavage at the extracellular domain of Rh(D) polypeptide. In contrast, such treatment of cells having various Rh(D) positive and negative phenotypes showed that the (C/c) and (E/e) antigen-containing polypeptides were not susceptible to cleavage. This suggests that the structure of the extracellular domain of Rh(D) polypeptide is unique among Rh antigens and could possibly be a factor contributing to its superior immunogenicity. It also appears that the 30-Kd cleavage product of the Rh(D) polypeptide either still contains one or more intact D antigenic epitopes or is associated in some way with undigested polypeptide, since both are recovered by immune complex formation using human polyclonal anti-D. The former explanation seems more likely because Gorick et alZ5reported the presence of at least three epitopes on the Rh(D) polypeptide and believe these epitopes to be present at varying depths within the lipid bilayer. Digestion of unsealed ghosts and inside-out vesicles with trypsin resulted in the cleavage of Rh(D), (C/c), and (E/e) polypeptides, thus confirming that they span the lipid bilayer. The size of the digestion products obtained from ghosts and vesicles of Rh(D) positive and negative cells was the same, indicating similar cytoplasmic domains for the Rh(D), (C/c), and (E/e) polypeptides. However, the size of the products of Rh(D) polypeptide from ghosts and vesicles of -D - / - D - cells was significantly higher. These bands were not discernible in the digests obtained from other Rh(D) positive cells. Although our evidence is not conclusive, it could reflect a difference in folding of the Rh(D) polypeptide within the lipid bilayer and at the cytoplasmic domain in -D-/-Dcells where other common Rh antigens are lacking. ACKNOWLEDGMENT We thank E. Rotter and S. Colt for their expert technical assistance; Dr L. Lenny for her critical reading of the manuscript, and the Philip Levine Laboratory, Ortho Diagnostic Systems, Inc, for providing Rh-null, - D - / - D- ,cdE/cdE, and Cde/cde erythrocytes. REFERENCES 1. Gahmberg CG: Molecular characteristics of the blood group Rh,,(D) molecule, in Harris J R ( 4 ) : Subcellular Biochemistry, vol 12. New York, NY, Plenum, 1988, p 95 2. Moore S, Woodrow CF, McClelland DBL: Isolation of membrane components associated with human red cell antigens Rh,(D), (c), (E) and Fy". Nature 295529.1982 3. Gahmberg CG: Molecular identification of the human Rho(D) antigens. FEBS Lett 40:93, 1982 4. Ridgwell K,Roberts SJ, Tanner MJA, Anstee DJ: Absence of two membrane proteins containing extracellular thiol groups in Rh null human erythrocytes. Biochem J 213:267,1983 5. Suyama K, Goldstein J Isolation of a red cell membrane component expressing Rh(D) antigenicity. J Cell Biol 103:69A, 1986 (abstr) 6. Agre P, Saboori AM, Asimos A, Smith B L Purification and partialcharacterization of the Mr 30,000 integral membrane protein associated with the Rh(D) antigen. J Biol Chem 262:17497,1987 7. Bloy C, Blanchard D, Lambin P, Goossens D, Rouger P, Salmon C, Cartron J - P Human monoclonal antibody against Rh(D) antigen: Partial characterization of the Rh(D) polypeptide from human erythrocytes. Blood 69:1491,1987 8. Suyama K, Goldstein J Antibody produced against isolated Rh(D) plypeptide reacts with other Rh-related antigens. Blood 721622,1988 9. Gahmberg CG: Molecular characterization of the human red cell W ( D ) antigen. EMBO J 2:223,1983 10. deVetten MP, Agre P The Rh polypeptide is a major fatty acid acylated erythrocyte membrane protein. J Biol Chem 263: 18193,1988 11. Bloy C, Blanchard D, Dahr W, Beyreuther K, Salmon C, Cartron J - P Determination of the N-terminal sequence of human red cell Rh(D) polypeptide and demonstration that the Rh(D), (c) and (E) antigens are carried by distinct polypeptide chains. Blood 72:661, 1988 12. Saboori AM, Smith BL, Agre P: Polymorphism in the Mr 32,000 Rh protein purified from Rh(D)-positive and negative erythrocytes. Proc Natl Acad Sci USA 85:4042, 1988 13. Avent ND, Ridgwell K, Mawby WJ, Tanner MJA, Anstee DJ, Kumpel B: Protein-sequence studies on Rh-related polypeptides suggest the presence of at least two groups of proteins which associate in the human red cell membrane. Biochem J 256:1043, 1988 14. Moore S, Green C: The identification of specific Rhesuspolypeptide-blood group-ABH-active-glycoprotein complexes in the human red-cell membrane. Biochem J 244:735,1987 15. Kramer M, Prohaska R: Characterization of human red cell and Rh (Rhesus)-specific polypeptides by limited proteolysis. FEBS Lett 226:105, 1987 16. Blanchard D, Bloy C, Hermand P, Cartron J-P, Saboori AM, Smith BL, Agre P: Two-dimensional iodopeptide mapping demonstrates that erythrocyte Rh D, c and E polypeptides are structurally homologous but nonidentical. Blood 72:1424, 1988 17. Suyama K, Goldstein J: The presence of Rh antigens on different polypeptide chains. J Cell Biol 107:561a, 1988 (abstr) 18. Verkleij AJ, Zwaal RFA, Roelofsen B, Comfurius P, Kastelijn D, van Deenen LLM: The asymmetric distribution of phospholip ids in the human red cell membrane. A combined study using phospholipases and freeze-etched electron microscopy. Biochem Biophys Acta 323:178, 1973 19. Jennings ML, Adams-Lackey M, Denny GH: Peptides of 260 human erythrocyte band 3 protein produced by extracellular papain cleavage. J Biol Chem 259:4652, 1984 20. Steck T, Kant JA: Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes, in Fleischer S, Packer L (eds): Methods in Enzymology, Biomembranes, vol 31, part A. San Diego, CA, Academic, 1974, p 172 21. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T,. Nature 227:680,1970 22. Burnette WN: "Western blotting": Electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gel to SUYAMA AND GOLDSTEIN unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Ann Biwhem 112:195, 1981 23. Green FA: Erythrocyte membrane phosphatidylcholine and Rh(D) antigen cryolatency. Immunol Commun 11:25, 1982 24. Rearden A: Phospholipid dependence of Wrb antigen expression in human erythrocyte membranes. Vox Sang 49:346,1985 25. Gorick BD, Thompson KM, Melamed MD, Hughes-Jones NC: Three epitopes on the human Rh antigen D recognized by '*'I-labelled human monoclonal IgG antibodies. Vox Sang 55:165, 1988